Clinical and endoscopic aspects of metastases to the gastrointestinal tract

Nenhuma Miniatura disponível
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2019
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
GEORG THIEME VERLAG KG
Autores
BATISTA, Clelma Pires
Citação
ENDOSCOPY, v.51, n.7, p.646-652, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background Studies that describe metastases to the gastrointestinal (GI) tract are restricted to small case series. An increase in the frequency of this condition is expected, so it would be useful to better characterize the endoscopic aspects of metastasis to the GI tract. The aims of this study were to describe the frequency and endoscopic features of the lesions, and to analyze the survival rate after diagnosis of metastasis. Methods This was a retrospective, single-center, observational study, conducted between 2009 and 2017. Patients with metastasis to the GI tract were included. Results 95 patients were included. Melanoma (25.3%), lung (15.8%), and breast (14.7%) were the most frequent primary tumors. The most common endoscopic presentation was a solitary, ulcerated lesion in the gastric body. Conventional biopsy was diagnostic in 98.9% of the cases. The mean and median survival rates were 13.3 months (95% confidence interval [CI] 8.2 - 18.3) and 4.7 months (95%CI 3.7 - 5.6), respectively. Palliative treatment with chcmo and/or radiotherapy after the diagnosis of the metastasis was related to a higher survival rate. Conclusions Melanoma, lung, and breast cancer were the most common primary tumors to metastasize to the Cl tract. The endoscopic features could not predict the primary site of the tumor. The finding of metastasis in the GI tract is related to the final stage of the cancer disease but patients who received palliative treatment with chemo and/or radiotherapy after diagnosis of Cl metastasis had higher survival rates.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/34015
Referências
  1. ABRAMS HL, 1950, CANCER, V3, P74, DOI 10.1002/1097-0142(1950)3:1<74::AID-CNCR2820030111>3.0.CO;2-7
  2. Alizadeh AM, 2014, TUMOR BIOL, V35, P8483, DOI 10.1007/s13277-014-2421-z
  3. De Palma GD, 2006, WORLD J GASTROENTERO, V12, P7326
  4. Gilg MM, 2018, GASTROINTEST ENDOSC, V88, P151, DOI 10.1016/j.gie.2018.02.019
  5. Kim GH, 2015, GUT LIVER, V9, P615, DOI 10.5009/gnl14032
  6. Kobayashi O, 2004, WORLD J SURG, V28, P548, DOI 10.1007/s00268-004-7216-8
  7. Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031
  8. MADEYA S, 1993, LEBER MAGEN DARM, V23, P77
  9. Mizobuchi S, 1997, JPN J CLIN ONCOL, V27, P410, DOI 10.1093/jjco/27.6.410
  10. Moreto M, 2003, ENDOSCOPY, V35, P36, DOI 10.1055/s-2003-36398
  11. Namikawa T, 2014, SURG TODAY, V44, P1392, DOI 10.1007/s00595-013-0671-9
  12. Oda I, 2001, ENDOSCOPY, V33, P507, DOI 10.1055/s-2001-14960
  13. Petersen RP, 2007, J THORAC CARDIOV SUR, V133, P104, DOI 10.1016/j.jtcvs.2006.08.065
  14. Riihimaki M, 2014, LUNG CANCER, V86, P78, DOI 10.1016/j.lungcan.2014.07.020
  15. Sandru A, 2014, J Med Life, V7, P572
  16. Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI 10.3322/caac.21332
  17. Sleeman JP, 2012, SEMIN CANCER BIOL, V22, P174, DOI 10.1016/j.semcancer.2012.02.007
  18. TELERMAN A, 1985, ENDOSCOPY, V17, P99, DOI 10.1055/s-2007-1018470
  19. Toreson WE, 1944, ARCH PATHOL, V38, P0082
  20. Ufen MP, 2014, ANN ONCOL, V25, P95, DOI 10.1093/annonc/mdt429
  21. Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024
  22. Wei SC, 2007, J GASTROEN HEPATOL, V22, P827, DOI 10.1111/j.1440-1746.2006.04532.x

Coleções
Artigos e Materiais de Revistas Científicas - FM/MGT
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/24
Artigos e Materiais de Revistas Científicas - LIM/37
Carregar mais